Neurocrine Biosciences Inc

NEW
FRA:NB3 (USA)   Ordinary Shares
€ 146.95 -1.65 (-1.11%) Jul 17
26.33
P/B:
5.04
Market Cap:
€ 15.09B ($ 17.26B)
Enterprise V:
€ 14.29B ($ 16.35B)
Volume:
50.00
Avg Vol (2M):
78.00
Trade In:

Neurocrine Biosciences Inc (FRA:NB3) Dividend

Neurocrine Biosciences Inc (FRA:NB3) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -1.2%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: FRA:NB3 Dividend

Does Neurocrine Biosciences Inc (FRA:NB3) pay a dividend?

Neurocrine Biosciences Inc (FRA:NB3) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Neurocrine Biosciences Inc pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Neurocrine Biosciences Inc has returned capital to shareholders via buybacks at a rate of -1.2% over the past 3 years.

What are dividend-paying alternatives to Neurocrine Biosciences Inc?

For dividend-paying alternatives in Neurocrine Biosciences Inc's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.